Thursday, October 12, 2023
8 am PT, 11 am ET, 17:00 CET
A fundamental research question resonates in the face of growing pandemic threats: How can we proactively develop countermeasures against future viral outbreaks? A critical component of future responses will be innovative research tools, including pseudoviruses that enable the safe study of highly pathogenic viruses in BSL-2 facilities. In this webinar, leaders in industry and academia discuss their experiences using such tools to study and develop therapeutics against influenza, SARS-CoV-2, and dengue viruses.
- Using pseudovirus Reporter Virus Particles (RVPs) in place of live viruses, featuring their utility for neutralization assays and determining antibody titers
- The flexibility of RVPs, and the ease of generating modified versions that allow the safe study of new virus variants and mutations of interest
- Case studies illustrating the use of innovative research tools—including pseudoviruses and epitope mapping—in developing vaccines and treatments for a range of viral pathogens